Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Investment: Sharewatch

Tuesday 30 March 1999 17:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

BUY

Although GKN should see a slowdown in their core automotive division, the stock's growth profile can ride on the back of the continued success of the industrial services division and positive news from the aerospace and special vehicle division, says BT Alex.Brown, which has upgraded the shares (956p) to a buy. The stock justifies a target a share price of pounds 11, the broker adds. Improving prospects for the industry, sustained growth in earnings and a relatively modest rating makeNorthern Leisure shares (134p) are very attractive, argues Teather & Greenwood. The market for nightclubs is very fragmented, giving it ample scope to grow at the rate of around 15 sites a year, predominatly purchased from independent operators. Each acquisition costs pounds 1.5-pounds 2m, a 30 per cent return is targeted and contribution to pre-tax profits from a new site is around pounds 200,000, adds TG.

SELL

Avoid Cortecs (21p), says Sutherlands, which points out that an independent report into its scientific programmes is due shortly. The biotech company commissioned the report last year after it announced its three lead programmes were not as advanced as had been indicated, and also undertook a review of its systems and pipeline to try to reduce cashburn itself.

HOLD

South African Breweries 20 per cent-plus outperformance meant that the shares (570p) have exceeded the initial price objective of 530p, says Merrill Lynch, which has now cut its intermediate recommendation to neutral.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in